Orange Book product
PIPERACILLIN AND TAZOBACTAM EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL
Orange Book ANDA 203719 · FRESENIUS KABI ANTI INFECTIVES SRL · Prescription
Key facts
| Proprietary name | PIPERACILLIN AND TAZOBACTAM |
|---|---|
| Active ingredients | PIPERACILLIN SODIUM, TAZOBACTAM SODIUM |
| Strength | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Application | ANDA203719 |
| Applicant holder | FRESENIUS KABI ANTI INFECTIVES SRL |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AP |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | May 18, 2018 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.